Tag archive for ‘Teva’
Jewish Business News On Monday, September 11th, 2017

Israeli Troubled Teva Appoints Kare Schultz CEO

Facebook0 Twitter Google Plus0 Pinterest0 Email   Teva‘s share price is up by more than 8% on the Tel Aviv Stock Exchange after the Israeli pharmaceutical company Named its new Kare Schultz as President More...

Jewish Business News On Sunday, August 20th, 2017

Teva Launches Generic Testosterone Boost Treatment

Facebook0 Twitter Google Plus0 Pinterest0 Email Teva Pharmaceutical Industries Ltd. today announced the launch of generic Axiron (testosterone) topical solution CIII, 30 mg/1.5 mL, in the US. Testosterone topical More...

Jewish Business News On Thursday, August 3rd, 2017

Teva Wiped Out $6.1 Billion and Cut Forecasts for 2017

Facebook0 Twitter Google Plus0 Pinterest0 Email Teva Pharmaceutical Industries said on Thursday it would continue to pursue a breach of contract suit against the former owners of its Rimsa plant in Mexico after More...

Jewish Business News On Sunday, May 7th, 2017

Teva and Active Biotech Announce CONCERTO Trial of Laquinimod Trial Fails

Facebook0 Twitter Google Plus0 Pinterest0 Email    Teva Pharmaceutical Industries Ltd. and its partner Active Biotech reported on Friday that the CONCERTO trial of its ethical drug laquinimod in patients More...

Shai Genish On Wednesday, February 8th, 2017

Israel Police Investigate Teva Bribery Allegations

Facebook0 Twitter Google Plus0 Pinterest0 Email   Teva bribery: Israeli police’s National Fraud Investigation Unit have opened an investigation against Teva Pharmaceutical Industries after it reached More...

Jewish Business News On Tuesday, February 7th, 2017

Teva CEO Erez Vigodman Unexpectedly Resigns Effective Immediately

Facebook0 Twitter Google Plus0 Pinterest0 Email Teva : L-R Erez Vinograd, Yitzhak Peterburg Israeli generic drugmaker Teva Pharmaceutical Industries Ltd announced last night that Teva CEO Erez Vigodman has resigned More...

Jewish Business News On Thursday, November 10th, 2016

Leading Israeli Women Honored at NYSE

Facebook0 Twitter Google Plus0 Pinterest0 Email   For Public Relations and Marketing use only. Not for any additional use unless a written permission granted by SA PRO, Inc. As part of the 10th annual Israel More...

Jewish Business News On Tuesday, September 20th, 2016

Teva Buys Rights to Regeneron Chronic Pain Drug for $250 Million

Facebook0 Twitter Google Plus0 Pinterest0 Email Teva Pharmaceutical Industries  and Regeneron Pharmaceuticals. today announced an agreement to develop and commercialize pain drug fasinumab, Regeneron’s More...

AAI Letter to the FTC: Generic Pharmaceutical Merger TEVA and ALLERGAN Will Eliminate Important Competition

Facebook0 Twitter Google Plus0 Pinterest0 Email In a letter to the Federal Trade Commission (FTC), The American Antitrust Institute (AAI), a non-profit organization, outlined the competitive concerns More...

Jewish Business News On Wednesday, November 25th, 2015

Teva Pharmaceuticals Licenses Migraine Treatment Candidates

Facebook0 Twitter Google Plus0 Pinterest0 Email   Teva Pharmaceutical Industries Ltd. and UK-based Heptares Therapeutics, a subsidiary of Tokyo-based Sosei Group have announced a licensing of its migraine More...

Email:

Delivered by FeedBurner